Transgene company information, Employees & Contact Information

Availability of Transgene’s Half-Year Financial Report as of June 30, 2025 GlobeNewswire

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ̶ Strong Outlook for 2025 Yahoo Finance

TNG - Transgene provides business and financial update for Q1 2024 ADVFN

Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data  Randomization to be Completed in Phase II Part in Q4 2025 GlobeNewswire

Data from Transgene and NEC Confirm Proof of Principle for Cancer Vaccine TG4050: Press Releases NEC Global

Availability of Transgene’s 2024 Universal Registration Document (URD) Yahoo Finance

Viral delivery of an RNA-guided genome editor for transgene-free germline editing in Arabidopsis Nature

2025 Half-year financial information GlobeNewswire

Novel recombinant adeno-associated viruses for Cre activated and inactivated transgene expression in neurons Frontiers

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer NEC Global

The regulation of reporter transgene expression for diverse biological imaging applications Nature

Transgene to Provide Updated Phase I Data in a Rapid Oral GlobeNewswire

Transgene, NEC, and BostonGene Expand Trial of Neoantigen Cancer Vaccine TG4050: Press Releases NEC Global

Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci Nature

Transgene and NEC Present New Data on TG4050 at ASCO 2023: Press Releases NEC Global

Transgene to Present 24-month Disease-Free Survival Data GlobeNewswire

Transgene and NEC Present Clinical Benefits of Neoantigen Cancer Vaccine TG4050: Press Releases NEC Global

Transgene and NEC announce preliminary data from Phase I studies of TG4050: Press Releases NEC Global

Transgene and NEC Start Two Clinical Trials with TG4050: Press Releases NEC Global

Cryopreservation does not change the performance and characteristics of allogenic mesenchymal stem cells highly over-expressing a cytoplasmic therapeutic transgene for cancer treatment Stem Cell Research & Therapy

High-throughput detection of T-DNA insertion sites for multiple transgenes in complex genomes BMC Genomics

Metabolic engineering generates a transgene-free safety switch for cell therapy Nature

Transgene and NEC demonstrate AI-based neoantigen prediction for cancer vaccine: Press Releases NEC Global

Transgene Provides Update on Phase II Trial of Therapeutic GlobeNewswire

Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A Nature

NEC and Transgene collaborate in the field of individualized cancer immunotherapy: Press Releases NEC Global

French cancer vaccine shows promise against recurrent tumours RFI

Optimization of overlap extension PCR for efficient transgene construction ScienceDirect.com

Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas | Cell Death & Disease Nature

Transgene Biocontainment Strategies for Molecular Farming Frontiers

The Q System: A Repressible Binary System for Transgene Expression, Lineage Tracing, and Mosaic Analysis ScienceDirect.com

Transgene présente des données de survie sans récidive à 24 GlobeNewswire